The effects of alpha-thalassaemia in HbSC disease.
In HbSC disease, as in sickle cell anaemia, there is a spectrum of clinical severity. A reduced mean corpuscular volume and haemoglobin concentration, traits typical of thalassaemia, might retard sickling. We therefore ascertained the prevalence of alpha-thalassaemia in 53 adults with HbSC disease and related alpha-globin gene deletion to the haematologic and clinical findings. Alpha-globin genotype was identified by restriction endonuclease gene mapping. Indirect ophthalmoscopy and fluorescein angiography were used to document the presence of proliferative retinopathy. Bone necrosis and infarction were determined roentgenographically or by radionuclide scanning. Either heterozygous or homozygous alpha-thalassaemia-2 was present in 26% of patients. There was no relationship between alpha-globin genotype and haematocrit, pain crises, bone lesions, proliferation retinopathy or clinical severity score.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000755:Anemia, Sickle Cell / Q000150:complications*; D001847:Bone Diseases / Q000150:complications; D004247:DNA; D004906:Erythrocyte Count; D004909:Erythrocyte Indices; D005260:Female; D005838:Genotype; D005914:Globins / Q000235:genetics; D006450:Hemoglobin SC Disease / Q000150:complications*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D012156:Reticulocytes; D012164:Retinal Diseases / Q000150:complications; D013789:Thalassemia / Q000150:complications*
D006454:Hemoglobins; D005914:Globins; D004247:DNA